Casdin Capital as of Sept. 30, 2021
Portfolio Holdings for Casdin Capital
Casdin Capital holds 54 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invitae (NVTAQ) | 8.6 | $347M | 12M | 28.43 | |
| Biolife Solutions Com New (BLFS) | 8.0 | $320M | 7.6M | 42.32 | |
| EXACT Sciences Corporation (EXAS) | 5.6 | $225M | 2.4M | 95.45 | |
| Pacific Biosciences of California (PACB) | 5.1 | $204M | 8.0M | 25.55 | |
| Fate Therapeutics (FATE) | 5.0 | $202M | 3.4M | 59.27 | |
| Alnylam Pharmaceuticals (ALNY) | 4.7 | $189M | 1.0M | 188.81 | |
| Maxcyte (MXCT) | 4.2 | $171M | 14M | 12.21 | |
| Blueprint Medicines (BPMC) | 4.0 | $159M | 1.6M | 102.81 | |
| Somalogic Class A Com | 3.8 | $154M | 12M | 12.39 | |
| Verve Therapeutics (VERV) | 3.6 | $143M | 3.0M | 47.00 | |
| Relay Therapeutics (RLAY) | 2.9 | $116M | 3.7M | 31.53 | |
| Twist Bioscience Corp (TWST) | 2.7 | $107M | 1.0M | 106.97 | |
| Sarepta Therapeutics (SRPT) | 2.5 | $102M | 1.1M | 92.48 | |
| Codexis (CDXS) | 2.5 | $101M | 4.3M | 23.26 | |
| Agios Pharmaceuticals (AGIO) | 2.5 | $100M | 2.2M | 46.15 | |
| Absci Corp (ABSI) | 2.2 | $90M | 7.7M | 11.63 | |
| Denali Therapeutics (DNLI) | 2.1 | $86M | 1.7M | 50.45 | |
| Ginkgo Bioworks Holdings Cl A Shs (DNA) | 2.1 | $84M | 7.2M | 11.59 | |
| Century Therapeutics (IPSC) | 2.0 | $81M | 3.2M | 25.16 | |
| Revolution Medicines (RVMD) | 1.9 | $77M | 2.8M | 27.51 | |
| Caredx (CDNA) | 1.9 | $76M | 1.2M | 63.37 | |
| Tenaya Therapeutics (TNYA) | 1.8 | $74M | 3.6M | 20.65 | |
| Beam Therapeutics (BEAM) | 1.8 | $71M | 819k | 87.01 | |
| Tango Therapeutics (TNGX) | 1.8 | $71M | 5.5M | 12.93 | |
| Dermtech Ord ord (DMTK) | 1.4 | $56M | 1.7M | 32.11 | |
| Beigene Sponsored Adr (BGNE) | 1.4 | $55M | 150k | 363.00 | |
| Allogene Therapeutics (ALLO) | 1.3 | $54M | 2.1M | 25.70 | |
| Global Blood Therapeutics In | 1.2 | $49M | 1.9M | 25.48 | |
| Adaptive Biotechnologies Cor (ADPT) | 1.2 | $49M | 1.4M | 33.99 | |
| Sema4 Holdings Corp Com Cl A | 0.9 | $38M | 5.0M | 7.59 | |
| Alector (ALEC) | 0.9 | $38M | 1.7M | 22.82 | |
| Generation Bio (GBIO) | 0.8 | $33M | 1.3M | 25.07 | |
| Singular Genomics Systems In (OMIC) | 0.8 | $30M | 2.7M | 11.19 | |
| 4d Molecular Therapeutics In (FDMT) | 0.7 | $30M | 1.1M | 26.97 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.7 | $30M | 266k | 111.93 | |
| Magenta Therapeutics | 0.7 | $28M | 3.9M | 7.28 | |
| Syndax Pharmaceuticals (SNDX) | 0.6 | $23M | 1.2M | 19.11 | |
| Monte Rosa Therapeutics (GLUE) | 0.5 | $21M | 961k | 22.28 | |
| Zai Lab Adr (ZLAB) | 0.5 | $20M | 190k | 105.39 | |
| 23andme Holding Class A Com (ME) | 0.4 | $17M | 1.8M | 9.06 | |
| 908 Devices (MASS) | 0.3 | $13M | 407k | 32.52 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.3 | $13M | 548k | 23.01 | |
| Oric Pharmaceuticals (ORIC) | 0.3 | $13M | 602k | 20.91 | |
| Kronos Bio (KRON) | 0.3 | $12M | 583k | 20.96 | |
| Vertex Pharmaceuticals Incorporated Call Option (VRTX) | 0.2 | $9.1M | 50k | 181.40 | |
| Decibel Therapeutics | 0.2 | $9.0M | 1.2M | 7.71 | |
| Alpha Teknova (TKNO) | 0.2 | $7.5M | 300k | 24.89 | |
| Orchard Therapeutics Ads | 0.1 | $5.9M | 2.6M | 2.30 | |
| Seer Com Cl A (SEER) | 0.1 | $5.2M | 150k | 34.53 | |
| Berkeley Lts | 0.1 | $3.9M | 200k | 19.56 | |
| Stoke Therapeutics (STOK) | 0.1 | $3.1M | 120k | 25.44 | |
| Foghorn Therapeutics (FHTX) | 0.1 | $3.0M | 215k | 13.93 | |
| Nautilus Biotechnology (NAUT) | 0.0 | $1.4M | 225k | 6.14 | |
| Sana Biotechnology (SANA) | 0.0 | $1.4M | 60k | 22.52 |
